1 |
Culliton BJ. Virus cancer program: review panel stands by criticism [J]. Science, 1974, 184(4133): 143-145.
|
2 |
Liu XY. Targeting gene-virotherapy of cancer and its prosperity [J]. Cell Res, 2006, 16(11): 879-86.
|
3 |
Zhang Y, Gu J, Zhao L, et al. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy [J]. Cancer Res, 2006, 66(8): 4291-4298.
|
4 |
McFadden G. Poxvirus tropism [J]. Nat Rev Microbiol, 2005, 3(3): 201-213.
|
5 |
Sanchez-Sampedro L, Perdiguero B, Mejias-Perez E, et al. The evolution of poxvirus vaccines [J]. Viruses, 2015, 7: 1726-803.
|
6 |
Di Lullo G, Soprana E, Panigada M, et al. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use [J]. J Virol Methods, 2010, 163(2): 195-204.
|
7 |
Juers DH, Matthews BW, Huber RE. LacZ beta-galactosidase: structure and function of an enzyme of historical and molecular biological importance [J]. Protein Sci, 2012, 21(12): 1792-1807.
|
8 |
Swenson ES, Price JG, Brazelton T, et al. Limitations of green fluorescent protein as a cell lineage marker [J]. Stem Cells, 2007, 25(10): 2593-600.
|
9 |
Gould SJ, Subramani S. Firefly luciferase as a tool in molecular and cell biology [J]. Anal Biochem, 1988, 175(1): 5-13.
|
10 |
Carroll MW, Moss B. E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses [J]. Biotechniques, 1995, 19(3): 352-354, 356.
|
11 |
Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells [J]. Mol Cell Biol, 1982, 2(9): 1044-1051.
|
12 |
Overbeek PA, Lai SP, Van Quill KR, et al. Tissue-specific expression in transgenic mice of a fused gene containing RSV terminal sequences [J]. Science, 1986, 231(4745): 1574-1577.
|
13 |
Zhu R, Liu Q, Huang W, et al. Comparison of the replication characteristics of vaccinia virus strains Guang 9 and Tian Tan in vivo and in vitro [J]. Arch Virol, 2014, 159(10): 2587-2596..
|
14 |
Zaitseva M, Kapnick SM, Meseda CA, et al. Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs [J]. J Virol, 2011, 85(17): 9147-9158.
|
15 |
Zhu W, Lei R, Le Duff Y, et al. The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA [J]. Retrovirology, 2015, 12: 22.
|
16 |
Chakrabarti S, Brechling K, Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques [J]. Mol Cell Biol, 1985, 5(12): 3403-3409.
|
17 |
Lorenzo MM, Blasco R. PCR-based method for the introduction of mutations in genes cloned and expressed in vaccinia virus [J]. Biotechniques, 1998, 24(2): 308-313.
|
18 |
Mackett M, Smith GL, Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes [J]. J Virol,1984, 49(3): 857-864.
|
19 |
Falkner FG, Moss B. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors [J]. J Virol, 1988, 62(6): 1849-1854.
|
20 |
Cui W, Liu L, Kodibagkar VD, et al. S-Gal, a novel 1H MRI reporter for beta-galactosidase [J]. Magn Reson Med, 2010, 64(1): 65-71.
|
21 |
Ghim CM, Lee SK, Takayama S, et al. The art of reporter proteins in science: past, present and future applications [J]. BMB Rep, 2010, 43(7): 451-460.
|
22 |
Rodriguez D, Gonzalez-Aseguinolaza G, Rodriguez JR, et al. Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium [J]. PLoS One, 2012, 7(4): e34445.
|
23 |
Gahan CG. The bacterial lux reporter system: applications in bacterial localisation studies [J]. Curr Gene Ther, 2012, 12(1): 12-19.
|
24 |
Yuan M, Gao X, Chard LS, et al. A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9 [J]. Mol Ther Methods Clin Dev, 2015, 2: 15035.
|
25 |
Falzarano D, Groseth A, Hoenen T. Development and application of reporter-expressing mononegaviruses: current challenges and perspectives [J]. Antiviral Res, 2014, 103: 78-87.
|